Page 3 - Licensing Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00777, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired bluebird securities between May 11, 2020 and November 4, 2020, both dates inclusive (the "Class Pe...

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird...

/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against bluebird bio, Inc....

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm Technologies, Tyson Foods, Clover Health Investments, and bluebird bio and Encourages Investors to Contact the Firm February 24, 2021 19:00 ET | Source: Bragar Eagel & Squire Bragar Eagel & Squire New York, New York, UNITED STATES NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhyt...